Combination risperidone and quetiapine therapy in refractory schizophrenia [2]

Canadian Journal of Psychiatry

Volumn 46, Issue 1, 2001, Pages 86-87

  Chue, P ^a   Welch, R ^a   Snaterse, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; PIMOZIDE; QUETIAPINE; RISPERIDONE; SULPIRIDE; VALPROIC ACID;

ADULT; AGGRESSION; CASE REPORT; DRUG MEGADOSE; DRUG POTENCY; HUMAN; LETTER; MALE; RECEPTOR AFFINITY; REFRACTORY PERIOD; SCHIZOPHRENIA; SEXUAL DYSFUNCTION;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; HUMANS; MALE; RISPERIDONE; SCHIZOPHRENIA; TREATMENT FAILURE;

EID: 0035089832     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. A positron emission tomography study of quetiapine in schizophrenia
2. Is there a place for antipsychotic polyphamacotherapy in schizophrenia?
3. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine
4. Review of quetiapine and its clinical applications in schizophrenia